Drebrin was used as a marker for changes in dendritic spines in murine models exhibiting AD-like pathology (Harigaya et al., 1996; Shim and Lubec, 2002; Shirao et al., 2017), as its presence across the spine is relatively uniform. Here, DBN1 is linked to Alzheimer disease.